These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34254292)

  • 1. Parkinson's disease in Sweden-resource use and costs by severity.
    Hjalte F; Norlin JM; Kellerborg K; Odin P
    Acta Neurol Scand; 2021 Nov; 144(5):592-599. PubMed ID: 34254292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and resource utilization-Swedish data from the Care of Late-Stage Parkinsonism (CLaSP) study.
    M Norlin J; Hjalte F; Kruse C; Dodel R; Rosqvist K; Odin P
    Acta Neurol Scand; 2022 Jun; 145(6):743-752. PubMed ID: 35312034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
    Hagell P; Nordling S; Reimer J; Grabowski M; Persson U
    Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson's Disease: A Swedish Register-Based Study in 1823 Observations.
    Norlin JM; Kellerborg K; Odin P
    Pharmacoeconomics; 2021 Oct; 39(10):1141-1149. PubMed ID: 34231134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug and treatment costs in Parkinson's disease patients in Sweden.
    Lökk J; Borg S; Svensson J; Persson U; Ljunggren G
    Acta Neurol Scand; 2012 Feb; 125(2):142-7. PubMed ID: 21470194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in resource utilization for Parkinson's disease in Germany.
    Winter Y; Balzer-Geldsetzer M; von Campenhausen S; Spottke A; Eggert K; Oertel WH; Dodel R
    J Neurol Sci; 2010 Jul; 294(1-2):18-22. PubMed ID: 20493500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Care of Late-Stage Parkinsonism: Resource Utilization of the Disease in Five European Countries.
    Kruse C; Lipinski A; Verheyen M; Balzer-Geldsetzer M; Wittenberg M; Lorenzl S; Richinger C; Schmotz C; Tönges L; Woitalla D; Klebe S; Bloem BR; Hommel A; Meissner WG; Laurens B; Boraud T; Foubert-Samier A; Vergnet S; Tison F; Costa N; Odin P; Rosqvist K; Norlin JM; Hjalte F; Schrag A; Dodel R
    Mov Disord; 2024 Mar; 39(3):571-584. PubMed ID: 38425158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The societal cost of schizophrenia in Sweden.
    Ekman M; Granstrom O; Omerov S; Jacob J; Landen M
    J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health economic costs of COPD in Sweden by disease severity--has it changed during a ten years period?
    Jansson SA; Backman H; Stenling A; Lindberg A; Rönmark E; Lundbäck B
    Respir Med; 2013 Dec; 107(12):1931-8. PubMed ID: 23910072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource Utilization of Patients with Parkinson's Disease in the Late Stages of the Disease in Germany: Data from the CLaSP Study.
    Kruse C; Kretschmer S; Lipinski A; Verheyen M; Mengel D; Balzer-Geldsetzer M; Lorenzl S; Richinger C; Schmotz C; Tönges L; Woitalla D; Klebe S; Schrag A; Dodel R
    Pharmacoeconomics; 2021 May; 39(5):601-615. PubMed ID: 33738776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of coronary heart disease and stroke: the case of Sweden.
    Zethraeus N; Molin T; Henriksson P; Jönsson B
    J Intern Med; 1999 Aug; 246(2):151-9. PubMed ID: 10447784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Relationship between PDQ-8 and Costs in Parkinson's Disease-A Swedish Register-Based Study.
    Kellerborg K; Norlin JM; Odin P
    Mov Disord Clin Pract; 2023 Feb; 10(2):231-237. PubMed ID: 36825055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic consequences of asthma among adults in Sweden.
    Jansson SA; Rönmark E; Forsberg B; Löfgren C; Lindberg A; Lundbäck B
    Respir Med; 2007 Nov; 101(11):2263-70. PubMed ID: 17689234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.
    Dodel RC; Singer M; Köhne-Volland R; Szucs T; Rathay B; Scholz E; Oertel WH
    Pharmacoeconomics; 1998 Sep; 14(3):299-312. PubMed ID: 10186468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic burden of prostate cancer - a Swedish prevalence-based register study.
    Hao S; Östensson E; Eklund M; Grönberg H; Nordström T; Heintz E; Clements M
    BMC Health Serv Res; 2020 May; 20(1):448. PubMed ID: 32434566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
    Winter Y; von Campenhausen S; Brozova H; Skoupa J; Reese JP; Bötzel K; Eggert K; Oertel WH; Dodel R; Ruzicka E
    Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK.
    Weir S; Samnaliev M; Kuo TC; Tierney TS; Walleser Autiero S; Taylor RS; Schrag A
    Mov Disord; 2018 Jul; 33(6):974-981. PubMed ID: 29603405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of Parkinson's disease among Filipino patients seen at a public tertiary hospital in Metro Manila.
    Prado M; Jamora RD
    J Clin Neurosci; 2020 Apr; 74():41-46. PubMed ID: 31983646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
    Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
    J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost of illness and health service patterns in Morbus Parkinson in Austria].
    von Campenhausen S; Winter Y; Gasser J; Seppi K; Reese JP; Pfeiffer KP; Geiger-Gritsch S; Bötzel K; Siebert U; Oertel WH; Dodel R; Poewe W
    Wien Klin Wochenschr; 2009; 121(17-18):574-82. PubMed ID: 19890747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.